May. 25 at 2:23 PM
$SANA Sana Biotechnology (SANA) is back in focus after Mayo Clinic agreed to collaborate on SC451 for type 1 diabetes and invest up to US
$50 million, linking clinical expertise with fresh capital support.,, DOWN about 15% from BUMP that this created, they bought in around
$3.35 I believe so anything under is a FREAT Buy